Appetite suppression peaks align differently with meal patterns
Our approach includes one-on-one medical consultations with providers experienced in peptide-based weight management, customized dosing protocols tailored to your tolerance and response, nutritional planning with emphasis on protein optimization and micronutrient support, ongoing progress monitoring with regular lab work and body composition analysis, and guidance on integrating physical activity to preserve lean mass and enhance results
however, dipeptidyl peptidase-4 (DPP-4) inhibitors and GLP-1RAs should not be combined (RCT, General)
Tirzepatide May Be Right for You If You have a BMI of 30 or higher, or 27 or higher with a weight-related health condition You want an FDA-approved medication with well-established clinical evidence You have type 2 diabetes and want to address both blood sugar and weight You prefer a treatment with extensive real-world safety data You have responded well to GLP-1 medications in the past and want enhanced results Retatrutide May Be Worth Discussing If You have significant weight to lose and want a more aggressive metabolic approach Previous dual-agonist or single-agonist therapies have plateaued You are interested in emerging therapies and are comfortable with newer clinical data You have concerns about fatty liver disease, given retatrutides potential hepatic benefits You want a treatment that addresses both appetite suppression and energy expenditure Important Medical Considerations Neither medication is appropriate for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Enroll in ENGAGING THE DISENGAGED Strategies for Promoting Behavior Change in Diabetes October 24, 2026 Transform how you engage patients with diabetes master behavior change, reduce distress, and overcome medication hesitancy
And suddenly, youre facing a completely new set of questions about these medications youve been taking
